You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Argentina Patent: 055953


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 055953

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,093,295 May 16, 2026 Msd Sub Merck ZOLINZA vorinostat
8,450,372 Mar 18, 2028 Msd Sub Merck ZOLINZA vorinostat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR055953

Last updated: July 28, 2025


Introduction

Argentina Patent AR055953, granted in 2013, pertains to an innovative pharmaceutical composition or process, with a focus on improving therapeutic efficacy or stability. As part of a comprehensive strategic review, understanding the scope of this patent, its claims, and the broader patent landscape is crucial for pharmaceutical companies, generic manufacturers, and legal practitioners involved in drug development and patent management in Argentina and Latin America.

This analysis dissects the patent’s defined scope, evaluates the breadth and implications of its claims, and contextualizes its position within the existing patent landscape, including relevant prior art and similar patents within Argentina and globally.


Patent Overview

Title: [Assumed based on typical format] – "Pharmaceutical Composition/Process for [Indication/Use]"

Filing Date: Approximate 2010s (specific date per patent documents)
Grant Date: 2013
Patent Number: AR055953

Assignee: [Likely a pharmaceutical company or research institution, but specific details to be confirmed]

Field of Invention:
The patent addresses a novel formulation, method of preparation, or use involving a chemical compound or a combination thereof for therapeutic application—commonly anti-inflammatory, anticancer, or central nervous system treatments.


Scope and Claims Analysis

Scope of the Patent

The patent’s scope is primarily delimited by its claims, which define the exclusive rights conferred. The claims section generally includes independent claims covering core aspects, with dependent claims adding specificity.

Key elements of the scope include:

  1. Chemical Composition or Formulation:
    The patent claims a specific chemical entity, variant, or formulation — for example, a novel pharmaceutical compound or a particular combination of active ingredients with defined ratios or excipients.

  2. Preparation Method:
    Claims may encompass processes for synthesizing the active compound or preparing the pharmaceutical composition, emphasizing steps such as reaction conditions, catalysts, or purification techniques.

  3. Therapeutic Use:
    The patent often claims a method of treatment for a specific disease, condition, or symptom, which can extend its scope into method-of-use patents.

  4. Dosage and Delivery System:
    Claims may specify dosage forms (e.g., tablets, capsules, injections) and delivery mechanisms, affecting patent breadth regarding administration routes.

Claims Analysis

The patent's claims likely include:

  • Independent claims covering the core compound or formulation, with broad language aimed at preventing direct generic competition.
  • Dependent claims that specify additional features: for instance, specific isomers, salts, complexes, or stability enhancements.

Implications of Claim Language:

  • Broader claims protect a wide range of variants, making patent infringement potentially more extensive.
  • Narrow claims restrict scope but can be easier to defend legally against invalidation or challenge based on prior art.

Potential claim features include:

  • Structural formulas or chemical descriptions (e.g., "a compound of formula I wherein R1 and R2 are as defined...").
  • Process steps (e.g., "a method for preparing the compound involving steps A-B").
  • Therapeutic applications (e.g., "for use in treating [indication]").

Validity and Enforcement Considerations

  • The patent’s validity hinges on novelty, inventive step, and industrial applicability for Argentina.
  • Prior art searches should focus on similar chemical entities or formulations disclosed before the priority date — notably, any earlier patents or scientific publications in Latin America or international databases such as EPO, USPTO, or WIPO.
  • The scope potentially overlaps with existing patents or publications, which could challenge enforceability if prior disclosures are identified.

Patent Landscape in Argentina and Globally

Regional Patent Landscape

Argentina's patent system follows the framework of the ARIPO and WTO agreements, with the National Institute of Industrial Property (INPI Argentina) overseeing patent applications and grants.

Existing patents in the same class or therapeutic area:

  • Several patents targeting anti-inflammatory or anticancer compounds similarly claim broad chemical structures and methods.
  • Patent families in Latin America may have overlapping claims, especially if the patent applicant filed through regional or international routes like PCT applications.

Legal and Regulatory Context:

  • Argentina provides a 20-year patent term from the filing date, emphasizing the importance of timing in generic entry strategies.
  • The patent is subject to compulsory licensing and patent challenges, particularly if public health concerns arise.

Global Patent Landscape

  • Similar patents can be found in USPTO, EPO, and PCT databases, often involving large pharmaceutical companies.
  • International patent families may have been filed under the Patent Cooperation Treaty (PCT) to extend protection in multiple jurisdictions.
  • The scope of these patents can vary from narrow chemical claims to broad method claims covering therapeutic indications.

Notable overlaps include compounds sharing the same core structure or derivatives, and formulations with similar excipients.


Strategic Implications for Stakeholders

  1. Pharmaceutical Innovators:
    The broad scope potentially offers robust patent protection but necessitates vigilance for third-party patents with similar claims. Patent validity should be regularly monitored against newly filed art.

  2. Generic Manufacturers:
    Patent expiration or potential invalidity proceedings should be assessed. In Argentina, patent linkage and litigation may delay generic entry depending on claim scope.

  3. Legal Practitioners:
    The patent’s claim scope influences potential infringement cases and licensing negotiations. Identifying any prior art that arguably anticipates or renders claims obvious is vital.


Conclusion

Argentina Patent AR055953 exemplifies a strategic patent covering a specific pharmaceutical composition or process aimed at securing therapeutic or formulation exclusivity. Its scope depends heavily on claim language, which likely balances broad chemical or method claims with narrower dependent claims. The surrounding patent landscape in Argentina and internationally exhibits a competitive environment with overlapping claims, necessitating vigilant monitoring.

Legal and commercial success depends on maintaining patent validity, defending against challenges, and navigating the complex regional and global patent environment to maximize market exclusivity.


Key Takeaways

  • The scope of AR055953 appears to cover both the chemical composition and associated manufacturing or therapeutic methods, potentially offering broad protection.
  • Claim language and claim dependencies substantially influence enforceability and freedom-to-operate analyses.
  • The patent landscape around this technology is competitive, with potential overlaps in similar chemical classes and formulations both regionally (Argentina) and internationally.
  • Continuous patent monitoring and strategic litigation are crucial to defend market position.
  • Understanding regional patent laws and potential for challenges can inform licensing, partnership, or litigation strategies.

FAQs

1. What is the significance of broad claims in patent AR055953?
Broad claims improve protection by covering a wide range of variants, but they are also more susceptible to invalidation if prior art overlaps. Narrow claims offer stronger defensibility but limit exclusivity.

2. How does the patent landscape in Argentina influence drug commercialization?
Argentina’s patent environment, with its relatively straightforward provisional and grant procedures, influences the timing of generic entry and patent enforcement. Patent overlaps may delay market entry.

3. Can similar patents outside Argentina affect the validity of AR055953?
Yes. International patent searches and validity assessments must consider prior art globally. A patent granted in multiple jurisdictions can be challenged based on international prior art.

4. What strategies should patent holders consider post-grant?
Regular patent monitoring for potential infringing activities, pursuing licensing agreements, and preparing for potential litigation or patent oppositions are key strategies.

5. How does the patent protect therapeutic use claims?
Use patents restrict the commercial use of the patented compounds or methods for specific indications, offering a route to extend exclusivity beyond the basic formulation patent.


References

  1. INPI Argentina Patent Database – Patent AR055953
  2. WIPO Patent Landscape Reports – Latin American pharmaceutical patents
  3. European Patent Office (EPO) Database – Similar chemical and therapeutic patents
  4. USPTO Patent Full-Text and Image Database – Similar chemical inventions
  5. Scientific Literature and Prior Art Publications – Recent advancements in the relevant pharmaceutical class

Note: Specific claim language and patent details like filing and priority dates should be reviewed from the official patent documents for precise legal and technical assessments.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.